Rules 4.7.3 and 4.10.3 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity MICROBA LIFE SCIENCES LIMITED ABN/ARBN Financial year ended: 82 617 096 652 30 JUNE 2026 Our corporate governance statement 1 for the period...
2026 Appendix 4G
Filed with ASX ·
On 6ix: 6ix.com/news/2026-appendix-4g-6
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings Call6ix hasn’t read this filing yet.
Microba Life Sciences Limited on 6ix
Story so far
Earlier from Microba Life Sciences
- 2026 Corporate Governance Statement
- Genetic Signatures and Microba in Merger Discussions
- Change of Director's Interest Notice - Pasquale Rombola
- Change of Director's Interest Notice - Prof Ian Frazer
- Cleansing Notice
Later from Microba Life Sciences
- 2026 Annual Report & Appendix 4E
- GSS and MAP agree to Commercial Terms for Merger
- Appointment of Interim Chief Executive Officer
- Change in substantial holding
- Microba launches GI Navigator in Australia and the UK
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences